This chapter, referred to in text, was in the original “this title”, meaning title VII of Pub. L. 105–277, div. C,
2018—Pub. L. 115–271, § 8202(b)(2), repealed Pub. L. 105–277, § 715. See 1998 Amendment note below.
Pub. L. 115–271, § 8202(b)(1), substituted “$18,400,000 for each of fiscal years 2018 through 2023” for “such sums as may be necessary for each of fiscal years 2006 through 2010”.
Pub. L. 115–271, § 8202(a), revived and restored this section as in effect on
2006—Pub. L. 109–469, § 602, amended Pub. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below.
Pub. L. 109–469, § 601, substituted “chapter except activities otherwise specified,” for “chapter,” and “2006 through 2010” for “1999 through 2003”.
1998—Pub. L. 105–277, § 715, as amended by Pub. L. 109–469, § 602, which provided for the repeal of this section effective
Provisions appropriating funds to carry out activities authorized by the Office of National Drug Control Policy Reauthorization Act of 1998, which enacted this chapter, were contained in the following appropriation acts:
Pub. L. 109–115, div. A, title V,
Pub. L. 108–447, div. H, title III,
Pub. L. 108–199, div. F, title III,